Clinical trials
Terminated Phase 1/2 trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genmab | 2 |
| Pfizer | 2 |
| Amgen | 1 |
| BerGenBio ASA | 1 |
| BioNTech SE | 1 |
| Kartos Therapeutics, Inc. | 1 |
| Kymab Limited | 1 |
| MedImmune LLC | 1 |
| Menarini Group | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 5 |
| Recurrence | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Carcinoma, Renal Cell | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Neoplasm Metastasis | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.